CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 22 enrolled
Drug / intervention
Cytospongedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02599558
NCT02599558N/ACompleted
CompareCT.gov

A Pilot Trial of Dietary Therapy Directed by the Esophageal Sponge in the Management of Eosinophilic Esophagitis.

Mayo Clinic·interventional·Posted Nov 6, 2015·Updated Dec 30, 2022

In Brief

A clinical study evaluating Cytosponge for Eosinophilic Esophagitis. Completed, enrolled 22 participants across 1 site.

Detailed Summary

This study is being done to see if the investigators can use only the cytosponge ( A 10 minute, in office procedure that does not require sedation) to replace the 6-10 endoscopies routinely perform during dietary restriction and food reintroduction in EoE?

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEosinophilic Esophagitis
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedNov 6, 2015
Enrollment StartNov 1, 2015
Primary CompletionJan 8, 2022
TodayJul 2, 2026
Enrollment to primary: 6.2 yearsPosted 10.7 years ago

Interventions

Cytospongedevice

A capsule with a string attached with a sponge inside is swallowed. The string is held without any tension to allow the capsule to move into the stomach. The string will be held for five minutes to allow the capsule to dissolve in the stomach; a round mesh sponge about the size of a quarter is released.